Advertisement

Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites

Published:October 16, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.10.009
      A risk score for atrial fibrillation (AF) has been developed by the Framingham Heart Study and Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)-AF consortium. However, validation of these risk scores in an inner-city population is uncertain. Thus, a validation model was built using the Framingham Risk Score for AF and CHARGE-AF covariates. An in and outpatient electrocardiographic database was interrogated from 2000 to 2013 for the development of AF. Patients were included if their age was >45 and <95 years, had <10-year follow-up, if their initial electrocardiogram was without AF, had ≥2 electrocardiograms, and declared a race and/or ethnicity as non-Hispanic white, African-American, or Hispanic. For the Framingham Heart Study, 49,599 patients met inclusion criteria, of which 4,860 developed AF. Discrimination analysis using area under the curve (AUC) for original risk equations: non-Hispanic white AUC = 0.712 (95% confidence interval [CI] 0.694 to 0.731), African-American AUC = 0.733 (95% CI 0.716 to 0.751), and Hispanic AUC = 0.740 (95% CI 0.723 to 0.757). For the CHARGE-AF, 45,571 patients met inclusion criteria, of which 4,512 developed AF. Non-Hispanic white AUC = 0.673 (95% CI 0.652 to 0.694), African-American AUC = 0.706 (95% CI 0.685 to 0.727), and Hispanic AUC = 0.711 (95% CI 0.691 to 0.732). Calibration analysis showed qualitative similarities between cohorts. In conclusion, this is the first study to validate both the Framingham Heart Study and CHARGE-AF risk scores in both a Hispanic and African-American cohort. All models predicted AF well across all race and ethnic cohorts.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • Chang Y.
        • Henault L.E.
        • Selby J.V.
        • Singer D.E.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
        JAMA. 2001; 285: 2370-2375
        • Miyasaka Y.
        • Barnes M.E.
        • Gersh B.J.
        • Cha S.S.
        • Bailey K.R.
        • Abhayaratna W.P.
        • Seward J.B.
        • Tsang T.S.
        Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
        Circulation. 2006; 114: 119-125
        • Benjamin E.J.
        • Wolf P.A.
        • D'Agostino R.B.
        • Silbershatz H.
        • Kannel W.B.
        • Levy D.
        Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
        Circulation. 1998; 98: 946-952
        • Schnabel R.B.
        • Sullivan L.M.
        • Levy D.
        • Pencina M.J.
        • Massaro J.M.
        • D'Agostino Sr., R.B.
        • Newton-Cheh C.
        • Yamamoto J.F.
        • Magnani J.W.
        • Tadros T.M.
        • Kannel W.B.
        • Wang T.J.
        • Ellinor P.T.
        • Wolf P.A.
        • Vasan R.S.
        • Benjamin E.J.
        Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.
        Lancet. 2009; 373: 739-745
        • Alonso A.
        • Krijthe B.P.
        • Aspelund T.
        • Stepas K.A.
        • Pencina M.J.
        • Moser C.B.
        • Sinner M.F.
        • Sotoodehnia N.
        • Fontes J.D.
        • Janssens A.C.
        • Kronmal R.A.
        • Magnani J.W.
        • Witteman J.C.
        • Chamberlain A.M.
        • Lubitz S.A.
        • Schnabel R.B.
        • Agarwal S.K.
        • McManus D.D.
        • Ellinor P.T.
        • Larson M.G.
        • Burke G.L.
        • Launer L.J.
        • Hofman A.
        • Levy D.
        • Gottdiener J.S.
        • Kaab S.
        • Couper D.
        • Harris T.B.
        • Soliman E.Z.
        • Stricker B.H.
        • Gudnason V.
        • Heckbert S.R.
        • Benjamin E.J.
        Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
        J Am Heart Assoc. 2013; 2: e000102
        • Amponsah M.K.
        • Benjamin E.J.
        • Magnani J.W.
        Atrial fibrillation and race—a contemporary review.
        Curr Cardiovasc Risk Rep. 2013; 7
        • Misialek J.R.
        • Rose K.M.
        • Everson-Rose S.A.
        • Soliman E.Z.
        • Clark C.J.
        • Lopez F.L.
        • Alonso A.
        Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study.
        J Am Heart Assoc. 2014; 3: e001159
        • Borzecki A.M.
        • Bridgers D.K.
        • Liebschutz J.M.
        • Kader B.
        • Kazis L.E.
        • Berlowitz D.R.
        Racial differences in the prevalence of atrial fibrillation among males.
        J Natl Med Assoc. 2008; 100: 237-245
        • Bush D.
        • Martin L.W.
        • Leman R.
        • Chandler M.
        • Haywood L.J.
        • NHLBI AFFIRM Investigators
        Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.
        J Natl Med Assoc. 2006; 98: 330-339
        • Dewland T.A.
        • Olgin J.E.
        • Vittinghoff E.
        • Marcus G.M.
        Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.
        Circulation. 2013; 128: 2470-2477
        • Eric Shulman
        U.S. Census Bureau.
        American FactFinder. 2015
        • Szklo M.
        • Barnes R.
        • Folsom A.
        • Heiss G.
        • Hutchinson R.
        • Patsch W.
        • Sharrett A.R.
        • Williams O.D.
        The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC Investigators.
        Am J Epidemiol. 1989; 129: 687-702
        • Fried L.P.
        • Borhani N.O.
        • Enright P.
        • Furberg C.D.
        • Gardin J.M.
        • Kronmal R.A.
        • Kuller L.H.
        • Manolio T.A.
        • Mittelmark M.B.
        • Newman A.
        • O'Leary D.
        • Psaty B.
        • Rautaharju P.
        • Tracy R.
        • Weiler P.
        The cardiovascular health study: design and rationale.
        Ann Epidemiol. 1991; 1: 263-276
        • Feinleib M.
        • Kannel W.B.
        • Garrison R.J.
        • McNamara P.M.
        • Castelli W.P.
        The Framingham Offspring study. Design and preliminary data.
        Prev Med. 1975; 4: 518-525
        • Harris T.B.
        • Launer L.J.
        • Eiriksdottir G.
        • Kjartansson O.
        • Jonsson P.V.
        • Sigurdsson G.
        • Thorgeirsson G.
        • Aspelund T.
        • Garcia M.E.
        • Cotch M.F.
        • Hoffman H.J.
        • Gudnason V.
        Age, Gene/Environment Susceptibility-Reykjavik study: multidisciplinary applied phenomics.
        Am J Epidemiol. 2007; 165: 1076-1087
        • Hofman A.
        • Breteler M.M.
        • van Duijn C.M.
        • Janssen H.L.
        • Krestin G.P.
        • Kuipers E.J.
        • Stricker B.H.
        • Tiemeier H.
        • Uitterlinden A.G.
        • Vingerling J.R.
        • Witteman J.C.
        The Rotterdam Study: 2010 objectives and design update.
        Eur J Epidemiol. 2009; 24: 553-572
        • IEC IS
        Particular Requirements for Safety, Including Essential Performance, of Recording and Analyzing Single Channel and Multichannel Electrocardiographs. Geneva, Switzerland: International Electrotechnical Commission.
        2003
        • Bogun F.
        • Anh D.
        • Kalahasty G.
        • Wissner E.
        • Bou Serhal C.
        • Bazzi R.
        • Weaver W.D.
        • Schuger C.
        Misdiagnosis of atrial fibrillation and its clinical consequences.
        Am J Med. 2004; 117: 636-642
        • Guglin M.E.
        • Thatai D.
        Common errors in computer electrocardiogram interpretation.
        Int J Cardiol. 2006; 106: 232-237
        • Poon K.
        • Okin P.M.
        • Kligfield P.
        Diagnostic performance of a computer-based ECG rhythm algorithm.
        J Electrocardiol. 2005; 38: 235-238
        • Feinberg W.M.
        • Blackshear J.L.
        • Laupacis A.
        • Kronmal R.
        • Hart R.G.
        Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.
        Arch Intern Med. 1995; 155: 469-473
        • Shen A.Y.
        • Contreras R.
        • Sobnosky S.
        • Shah A.I.
        • Ichiuji A.M.
        • Jorgensen M.B.
        • Brar S.S.
        • Chen W.
        Racial/ethnic differences in the prevalence of atrial fibrillation among older adults—a cross-sectional study.
        J Natl Med Assoc. 2010; 102: 906-913
        • Marcus G.M.
        • Alonso A.
        • Peralta C.A.
        • Lettre G.
        • Vittinghoff E.
        • Lubitz S.A.
        • Fox E.R.
        • Levitzky Y.S.
        • Mehra R.
        • Kerr K.F.
        • Deo R.
        • Sotoodehnia N.
        • Akylbekova M.
        • Ellinor P.T.
        • Paltoo D.N.
        • Soliman E.Z.
        • Benjamin E.J.
        • Heckbert S.R.
        • Candidate-Gene Association Resource Study
        European ancestry as a risk factor for atrial fibrillation in African Americans.
        Circulation. 2010; 122: 2009-2015
        • Ruo B.
        • Capra A.M.
        • Jensvold N.G.
        • Go A.S.
        Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.
        J Am Coll Cardiol. 2004; 43: 429-435
        • Upshaw Jr., C.B.
        Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study.
        J Natl Med Assoc. 2002; 94: 204-208
        • Alonso A.
        • Agarwal S.K.
        • Soliman E.Z.
        • Ambrose M.
        • Chamberlain A.M.
        • Prineas R.J.
        • Folsom A.R.
        Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.
        Am Heart J. 2009; 158: 111-117
        • Psaty B.M.
        • Manolio T.A.
        • Kuller L.H.
        • Kronmal R.A.
        • Cushman M.
        • Fried L.P.
        • White R.
        • Furberg C.D.
        • Rautaharju P.M.
        Incidence of and risk factors for atrial fibrillation in older adults.
        Circulation. 1997; 96: 2455-2461
        • Cutler J.A.
        • Sorlie P.D.
        • Wolz M.
        • Thom T.
        • Fields L.E.
        • Roccella E.J.
        Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.
        Hypertension. 2008; 52: 818-827
        • Schnabel R.B.
        • Aspelund T.
        • Li G.
        • Sullivan L.M.
        • Suchy-Dicey A.
        • Harris T.B.
        • Pencina M.J.
        • D'Agostino Sr., R.B.
        • Levy D.
        • Kannel W.B.
        • Wang T.J.
        • Kronmal R.A.
        • Wolf P.A.
        • Burke G.L.
        • Launer L.J.
        • Vasan R.S.
        • Psaty B.M.
        • Benjamin E.J.
        • Gudnason V.
        • Heckbert S.R.
        Validation of an atrial fibrillation risk algorithm in whites and African Americans.
        Arch Intern Med. 2010; 170: 1909-1917